ArticleFrontiers in molecular biosciences2026
Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.
Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it